# PPARγ activation rescues oxidative stress-induced embryonic arrest by suppressing Wnt/β-catenin signaling via GSK3β upregulation

**Authors:** Lihong Liu, Siyao Ha, Hui Chen, MingQing Li, Zhiling Li

PMC · DOI: 10.1016/j.isci.2026.114870 · 2026-01-30

## TL;DR

PPARγ activation helps embryos survive oxidative stress by regulating GSK3β and Wnt/β-catenin signaling, improving ART outcomes.

## Contribution

Identifies PPARγ as a key regulator of embryonic redox and metabolic homeostasis during oxidative stress.

## Key findings

- PPARγ activation rescues oxidative stress-induced embryonic arrest by scavenging ROS and restoring mitochondrial function.
- PPARγ upregulates GSK3β, which suppresses aberrant Wnt/β-catenin signaling in stressed embryos.
- The PPARγ agonist GW1929 restores redox and metabolic homeostasis in embryos exposed to oxidative stress.

## Abstract

Excessive reactive oxygen species (ROS) during assisted reproductive technology (ART) impairs embryonic development, yet the intrinsic molecular mechanisms remain inadequately understood. Through transcriptomic profiling (Drug-seq) of oxidatively stressed mouse embryos, we identified peroxisome proliferator-activated receptor gamma (PPARγ) as a critical regulator whose essential upregulation during zygotic genome activation (ZGA) is suppressed. Functional studies demonstrated that the pharmacological activation of PPARγ via the agonist GW1929 robustly rescued developmental arrest by scavenging ROS, restoring mitochondrial function, and maintaining metabolic homeostasis. Mechanistically, we demonstrate that PPARγ activation transcriptionally upregulates GSK3β, which in turn suppresses oxidative stress-induced aberrant Wnt/β-catenin signaling. Our findings establish PPARγ as a central guardian of embryonic redox and metabolic homeostasis, and propose PPARγ agonism as a potential strategy to improve ART outcomes by counteracting oxidative injury.

•PPARγ activation rescues oxidative stress-induced embryonic arrest•PPARγ upregulates GSK3β to suppress aberrant Wnt/β-catenin signaling•PPARγ agonist GW1929 restores redox/metabolic homeostasis in embryos

PPARγ activation rescues oxidative stress-induced embryonic arrest

PPARγ upregulates GSK3β to suppress aberrant Wnt/β-catenin signaling

PPARγ agonist GW1929 restores redox/metabolic homeostasis in embryos

Biological sciences; Developmental genetics; Developmental biology

## Linked entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932]
- **Chemicals:** GW1929 (PubChem CID 6518171)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Sod3 (superoxide dismutase 3, extracellular) [NCBI Gene 20657] {aka EC-SOD}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Igf2 (insulin-like growth factor 2) [NCBI Gene 16002] {aka Igf-2, Igf-II, M6pr, Mpr, Peg2}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Dkk1 (dickkopf WNT signaling pathway inhibitor 1) [NCBI Gene 13380] {aka mdkk-1}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Pou5f1 (POU domain, class 5, transcription factor 1) [NCBI Gene 18999] {aka NF-A3, Oct-3, Oct-3/4, Oct-4, Oct3, Oct3/4}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}
- **Diseases:** mitochondrial dysfunction (MESH:D028361), embryonic arrest (MESH:D018236), tumor (MESH:D009369), infertility (MESH:D007246), developmental arrest (MESH:D006323), cytotoxicity (MESH:D064420), developmental (MESH:C567924), developmental impairment (MESH:D007805), developmental defects (MESH:D000094602), metabolic dysfunction (MESH:D008659), embryonic dysfunction (MESH:D009373), IVF (MESH:C566179)
- **Chemicals:** Alexa Fluor (-), H2O2 (MESH:D006861), JC-1 (MESH:C068624), C11 BODIPY 581/591 (MESH:C120421), dUTP (MESH:C027078), GW9662 (MESH:C457499), Triton X-100 (MESH:D017830), lipid peroxides (MESH:D008054), ATP (MESH:D000255), water (MESH:D014867), CO2 (MESH:D002245), Lipid (MESH:D008055), iron (MESH:D007501), PBS (MESH:D007854), PVDF (MESH:C024865), SDS (MESH:D012967), GW1929 (MESH:C120099), glucose (MESH:D005947), DAPI (MESH:C007293), sc- (MESH:D012538), ROS (MESH:D017382)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924746/full.md

---
Source: https://tomesphere.com/paper/PMC12924746